South Africa End Use - Cancer Monoclonal Antibodies Market Statistics
South Africa end use cancer monoclonal antibodies market size was valued at US$ 631.5 million in 2023 and is estimated to grow at a compound annual growth rate (CAGR) of 10.7% from 2023 to 2030.